Alliance Pharma PLC (GB:APH)
LSE:APH
UK Market

Alliance Pharma Stock Analysis & Ratings

GB:APH Stock Chart & Stats

Day’s Range107.8p - 111.8p
52-Week Range52.17p - 91.00p
Previous Close108.2p
Volume823.12K
Average Volume (3M)1.31M
Market Cap600.96M
P/E Ratio88.3
Beta0.79
Next EarningsSep 21, 2022
Dividend Yield0.02 (1.04%)
Smart Score8
EPS (TTM)0.01


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

GB:APH FAQ

What was Alliance Pharma’s price range in the past 12 months?
Alliance Pharma lowest stock price was 52.17p and its highest was 91.00p in the past 12 months.
    What is Alliance Pharma’s market cap?
    Alliance Pharma’s market cap is 600.96M.
      What is Alliance Pharma’s price target?
      The average price target for Alliance Pharma is 130.00p. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is 130.00p ,the lowest forecast is 130.00p. The average price target represents 16.70% Increase from the current price of 111.4p.
        What do analysts say about Alliance Pharma?
        Alliance Pharma’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
          When is Alliance Pharma’s upcoming earnings report date?
          Alliance Pharma’s upcoming earnings report date is Sep 21, 2022 which is in 123 days.
            How were Alliance Pharma’s earnings last quarter?
            Alliance Pharma released its earnings results on Mar 22, 2022. The company reported -0.2p earnings per share for the quarter, missing the consensus estimate of 2.9p by -3.1p.
              Is Alliance Pharma overvalued?
              According to Wall Street analysts Alliance Pharma’s price is currently Undervalued.
                Does Alliance Pharma pay dividends?
                Alliance Pharma pays a Annually dividend of 1.13p which represents an annual dividend yield of 1.04%. Alliance Pharma’s last Annually dividend payment was on Jul 07, 2022. Alliance Pharma’s upcoming ex-dividend date is Jun 09, 2022
                  What is Alliance Pharma’s EPS estimate?
                  Alliance Pharma’s EPS estimate for its next earnings report is not yet available.
                  How many shares outstanding does Alliance Pharma have?
                  Alliance Pharma has 539,460,000 shares outstanding.
                    What happened to Alliance Pharma’s price movement after its last earnings report?
                    Alliance Pharma reported an EPS of -0.2p in its last earnings report, missing expectations of 2.9p. Following the earnings report the stock price went up 1.616%.
                      Which hedge fund is a major shareholder of Alliance Pharma?
                      Currently, no hedge funds are holding shares in GB:APH

                      ---

                      Alliance Pharma Stock Analysis

                      Smart Score
                      8
                      Outperform
                      1
                      2
                      3
                      4
                      5
                      6
                      7
                      8
                      9
                      10
                      Price Target
                      130.00p
                      ▲(16.70% Upside)
                      Moderate Buy

                      Analyst Forecast

                      Moderate Buy
                      Average Price Target: 130.00p

                      Blogger Sentiment

                      Bullish
                      GB:APH Sentiment 100% Sector Average 70%

                      Hedge Fund Holdings

                      N/A
                      Currently Not Enough Data Available

                      Insider Transactions

                      N/A
                      Currently Not Enough Data Available

                      Retail Investors

                      N/A
                      Currently Not Enough Data Available

                      News Sentiment

                      Neutral
                      Bullish 100% Bearish 0%

                      Technicals

                      SMA
                      Positive
                      20 days / 200 days
                      Momentum
                      17.93%
                      12-Months-Change

                      Fundamentals

                      Return on Equity
                      2.60%
                      Trailing 12-Months
                      Asset Growth
                      -1.05%
                      Trailing 12-Months
                      The Alliance Pharma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      Alliance Pharma PLC

                      Alliance Pharma PLC is a player in the healthcare market. The company's business includes acquisition, marketing, and distribution of pharmaceutical products. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol.

                      ---
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Advanced Medical Solutions
                      Abcam plc
                      Allergy Therapeutics
                      Iomart Group plc

                      Popular Stocks

                      ---
                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis